Pay in 4 interest-free payments of $34.75 Learn more
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4
LDN-57444 was used at 5-25 µM final concentration in various in vitro assays
15(1):39-48
selective and competitive inhibitor of adipose triglyceride lipase (ATGL) with an IC50 of ~0
Smiles: COC1=CC=CC=C1C(=O)NC1=CC2=C(C=C1N1CCCCC1)N(C)C(=O)N2C
It inhibited the activity of human PRC2-containing wild-type EZH2 with an inhibition constant (Ki) value of 2
IDH-C227 - IDH1 Inhibitor. CAS# 1355324-14-9 0232 LDN-57444 was used at 5-25IDH C227, CAS No. 1355324 14 9, is a potent and selective IDH1 R132H inhibitor first reported in patent WO2012009678. It can inhibit the enzymatic activity of IDH1 R132H in vitro with an IC50 < 0. 1 M, and 2 HG production in HT1080 and U87MG cells with IC50 < 0. 25 M. Because the mutated form of IDH1 produces the metabolite, 2 hydroxyglutarate (2HG), which may contribute to the formation and malignant progression of gliomas as well as other forms of
US$ 10065.50
US$ 93.80
US$ 1604.57
US$ 2172.93
US$ 1772.14
US$ 2033.63
US$ 425.80
US$ 1101.63
US$ 544.72
US$ 49.99